U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
(Image credit: Sam Yeh)
BlogZone shows headlines and summaries from public news feeds. The full story is published by NPR News.
Read the full story at NPR News →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.
